7 Best Stocks for the Next 30 Days

Get them in a free Special Report, and get more Zacks Insights in our free e-newsletter, Profit from the Pros. Every issue includes a fresh Zacks #1 Bull Stock of the Day.

Close This Panel X

Are you a new Zacks Member or a visitor to Zacks.com?

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Stocks on the Move 05/23/2013

Company Name Symbol %Change
ALLIANCE FIB AFOP
5.21%
CYNOSURE INC CYNO
4.42%
DAWSON GEOPH DWSN
4.33%
MARRIOT VAC VAC
3.27%
BLOOMIN BRAN BLMN
2.93%

Cosan Remains Neutral Rated

by Payal Jalan

September 04, 2012 | Comments : 0 Recommended this article: (0)

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

We recently maintained a Neutral recommendation on Brazilian sugar and ethanol producer, Cosan Limited (CZZ - Analyst Report).

Cosan’s long-term growth prospects appear bright with strategic acquisitions, growing sugar and ethanol demand, energy co-generation and transportation businesses acting as the major growth driving catalysts. Cosan’s dividend payments and share buyback activities are an added advantage for the company.

Formation of Raizen, a joint venture between Cosan and Shell, has proved to be a boon for the company enabling better access to the ethanol consumer market and increased competitiveness in biofuels and fuel distribution businesses. The joint venture is expected to be one of the largest ethanol producers in the world with 2.2 billion litres of annual production capacity.

Besides, Cosan’s association with Camil will bring recognised brands in sugar, rice and canned fish under one roof. Also, the acquisition of stakes in Comgas will strengthen Cosan’s presence in energy business while the additions of Esso Petroleum Company and Comma will solidify the company’s presence in the European lubricant and specialties markets. Share acquisition in América Latina Logística (ALL) will provide Cosan access to the former’s transportation services.

For fiscal year 2013, management anticipates that consolidated net revenue would be in the range of R$26.0-R$29.0 billion; EBITDA in the range of R$2.2-R$2.5 billion and capital expenditure in the range of R$2.1-R$2.4 billion.

Despite the solid long-term growth prospects, Cosan’s near-term performance has forced us to remain on the sidelines. Cosan posted disappointing fiscal first quarter 2013 results with a net loss of R$24 million as compared with earnings of R$986 million in the year-ago quarter. Revenue increased 18%, which was more than offset by a 23% jump in cost of sales.

The current Zacks Consensus Estimate for the fiscal second quarter of 2013 is 25 cents. Estimates for fiscal 2013 and 2014 are 71 cents and $1.48, reflecting annual growth of (72.8%) and 108.5%, respectively.

Cosan currently has a Zacks #3 Rank, translating into a short-term (1-3 months) Hold rating while its nearest competitor Archer Daniels Midland Company (ADM - Analyst Report) bears a Zacks #5 Rank, indicating a Strong Sell rating.

Email Print Share Rate Pos Rate Neg

Read/Post Comments (0) | Recommended this article (0)

Please login to Zacks.com or register to post a comment.

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.